— Know what they know.
Not Investment Advice

IMMX Smart Money

Immix Biopharma, Inc.
1W: -9.7% 1M: -29.8% 3M: -1.5% YTD: +48.2% 1Y: +123.0% 3Y: +172.9%
$8.05
-0.01 (-0.12%)
 
Weekly Expected Move ±9.7%
$7 $7 $8 $9 $10
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 28 · $667.4M mcap · 58M float · 3.03% daily turnover · Short 63% of daily vol
Credit Risk of going bust: lower than 74% of companies Debt: 0.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), Immix Biopharma, Inc. would be worth roughly what it owes.
Total debt $1.0M against a stock market value of $667.4M.
Distance to default 8.22 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $501K (short-term plus half of long-term), stock volatility 83.8%; Altman Z'' 26.88. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

🏦 Institutional Activity

Latest: Q2 2026
122
Institutions Holding
+33 vs prior
84.4%
Ownership
+5.35%
47 New
35 Increased
24 Reduced
11 Closed

👔 Insider Trades

14 records
Date Name Title Type Shares Price Value Filing
2026-05-22 Hsu Jason director A-Grant/Award 6,250 $— $0 Filing
2026-05-22 BUCHAN JANE director A-Grant/Award 6,250 $— $0 Filing
2026-05-22 Chudnovsky Yekaterina director A-Grant/Award 6,250 $— $0 Filing
2026-05-22 CHANG NANCY T director A-Grant/Award 6,250 $— $0 Filing
2026-05-22 Marquet Magda director A-Grant/Award 6,250 $— $0 Filing
2026-05-22 Adams Helen C. director A-Grant/Award 6,250 $— $0 Filing
2026-05-22 Ng Carey director A-Grant/Award 6,250 $— $0 Filing
2025-12-10 Morris Gabriel S officer: cfo P-Purchase 770 $6.58 $5K Filing
2025-12-10 Rachman Ilya M officer: ceo and chairman P-Purchase 746 $6.67 $5K Filing
2025-12-08 Morris Gabriel S officer: cfo X-Option Exercise 156,000 $0.80 $125K Filing
2025-09-17 Rachman Ilya M officer: ceo and chairman P-Purchase 2,500 $2.02 $5K Filing
2025-09-16 Morris Gabriel S officer: cfo P-Purchase 2,600 $1.97 $5K Filing
2025-06-18 Morris Gabriel S officer: cfo P-Purchase 2,225 $2.28 $5K Filing
2025-06-18 Rachman Ilya M officer: ceo and chairman P-Purchase 2,178 $2.29 $5K Filing

🏛️ Congressional Trades

0 records
Date Politician Chamber Type Amount Filing
No congressional trades found

🏦 Top Institutional Holders

20 holders
Holder Shares Value Date Reported Filing
Jupiter Topco LLC 9,783,192 $101M +9,783,192 2026-06-30 Filing
Saturn V Capital Management LP 4,658,429 $48M +964,844 2026-06-30 Filing
EVENTIDE ASSET MANAGEMENT, LLC 3,891,019 $40M +1,342,000 2026-06-30 Filing
STATE STREET CORP 2,996,935 $31M +2,805,025 2026-06-30 Filing
BlackRock, Inc. 2,989,972 $31M +2,521,595 2026-06-30 Filing
Deep Track Capital, LP 2,775,000 $29M +2,775,000 2026-06-30 Filing
VANGUARD CAPITAL MANAGEMENT LLC 2,507,122 $26M +719,128 2026-06-30 Filing
Opaleye Management Inc. 2,345,000 $24M +2,345,000 2026-06-30 Filing
MILLENNIUM MANAGEMENT LLC 2,066,426 $21M +316,226 2026-06-30 Filing
UBS Group AG 1,941,817 $20M +1,864,985 2026-06-30 Filing
MARSHALL WACE, LLP 1,794,908 $19M +153,356 2026-06-30 Filing
WELLINGTON MANAGEMENT GROUP LLP 1,473,409 $15M +1,473,409 2026-06-30 Filing
GREAT POINT PARTNERS LLC 1,277,642 $13M +927,642 2026-06-30 Filing
GEODE CAPITAL MANAGEMENT, LLC 1,201,097 $12M +737,713 2026-06-30 Filing
Velan Capital Investment Management LP 1,085,000 $11M +345,000 2026-06-30 Filing
Bleichroeder LP 1,000,000 $10M — 2026-06-30 Filing
Logos Global Management LP 1,000,000 $10M -225,000 2026-06-30 Filing
FRANKLIN RESOURCES INC 969,120 $10M +54 2026-06-30 Filing
Burkehill Global Management, LP 544,118 $6M +250,000 2026-06-30 Filing
AMERIPRISE FINANCIAL INC 518,881 $5M +518,881 2026-06-30 Filing

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms